Marrone Bio Innovations I...

NASDAQ: MBII · Real-Time Price · USD
0.80
-0.20 (-20.00%)
At close: Apr 24, 2025, 3:47 PM

Marrone Bio Innovations Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
44.31M
Cost of Revenue
17.06M
Gross Profit
27.25M
Operating Income
-14.94M
Interest Income
n/a
Pretax Income
-16.51M
Net Income
-16.55M
Selling & General & Admin
30.57M
Research & Development
12.08M
Other Expenses
n/a
Operating Expenses
42.65M
Interest Expense
1.57M
Selling & Marketing Expenses
n/a
Cost & Expenses
59.71M
Income Tax Expense
45K
Shares Outstanding (Basic)
174.83M
Shares Outstanding (Diluted)
174.83M
EPS (Basic)
-0.09
EPS (Diluted)
-0.09
EBITDA
-10.37M
EBIT
-14.94M
Depreciation & Amortization
4.57M